BDX
59
-2
CFG
89
-4
COF
65
-4
CAG
41
5
ADI
71
-2
AZO
42
-3
AEE
60
2
AVGO
42
-3
AMG
80
-2
C
79
-2
AAL
45
-3
APA
55
2
CNP
59
2
CCI
41
2
DD
38
-2
AMP
67
-3
BRK.B
45
3
BAX
39
-2
AAP
6
-2
DAL
68
-2
BDX
59
-2
CFG
89
-4
COF
65
-4
CAG
41
5
ADI
71
-2
AZO
42
-3
AEE
60
2
AVGO
42
-3
AMG
80
-2
C
79
-2
AAL
45
-3
APA
55
2
CNP
59
2
CCI
41
2
DD
38
-2
AMP
67
-3
BRK.B
45
3
BAX
39
-2
AAP
6
-2
DAL
68
-2
Financhill
Back

Novonesis (Novozymes A/S) Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58

NVZMY
Novonesis (Novozymes A/S)

Last Price:
$64.08
Seasonality Move:
3.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Novonesis (Novozymes A/S) Stock Forecast

  • Over the next 52 weeks, Novonesis (Novozymes A/S) has on average historically risen by 15.8% based on the past 22 years of stock performance.
  • Novonesis (Novozymes A/S) has risen higher in 16 of those 22 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
  • Is Novonesis (Novozymes A/S) Stock Undervalued?
    The current Novonesis (Novozymes A/S) [NVZMY] share price is $64.08. The Score for NVZMY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • NVZMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Novonesis (Novozymes A/S) Stock Go Up Next Year?

  • Over the next 52 weeks, Novonesis (Novozymes A/S) has on average historically risen by 15.8% based on the past 22 years of stock performance.

Novonesis (Novozymes A/S) Stock Rating

Buy
58
Novonesis (Novozymes A/S) (NVZMY) is a Buy

Is Novonesis (Novozymes A/S) overpriced?

  • Novonesis (Novozymes A/S) has risen higher in 16 of those 22 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%

Novonesis (Novozymes A/S) Stock Price History

Is NVZMY stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVZMY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Chemicals
Sector:
Materials
Type:
stock
Website:
novonesis.com

52-Week Data

52-Week High:
75.99
52-Week Low:
53.95

Prediction Charts

Market Cap:
29.8B
Price in USD:
64.08
Volume:
63.3K
Beta:
0.88

Technical Analysis

SMA50:
62.47
SMA100:
62.69
SMA200:
64.73
52-Wk Change:
11.79%

Stock Predictions

  • Is Novonesis (Novozymes A/S) stock public?
    Yes, Novonesis (Novozymes A/S) is a publicly traded company.
  • What is the Novonesis (Novozymes A/S) stock quote today?
    The Novonesis (Novozymes A/S) stock price is 64.08 USD today.
  • How to buy Novonesis (Novozymes A/S) stock online?
    You can buy Novonesis (Novozymes A/S) shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-9 62.15 61.99 62.58 61.34
Dec-10 61.11 61.97 61.97 60.93
Dec-11 61.38 61.68 61.88 61.37
Dec-12 61.80 62.09 62.33 61.73
Dec-15 61.52 61.57 62.71 60.64
Dec-16 62.12 61.64 62.30 61.01
Dec-17 60.94 61.67 62.14 60.94
Dec-18 62.69 63.18 64.00 62.69
Dec-19 63.40 63.31 63.71 62.70
Dec-22 63.07 63.07 63.46 62.76
Dec-23 63.90 63.94 64.75 63.15
Dec-24 65.00 64.25 66.00 61.45
Dec-26 65.53 63.89 66.00 61.52
Dec-29 64.34 64.08 65.25 63.09

Novonesis (Novozymes A/S) Earnings

Data Unavailable

Novonesis (Novozymes A/S) Forecast Revenue Growth

Data Unavailable

* Novonesis (Novozymes A/S) stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.